Report me for selling fake medicine? Why are you crying when your illness relapses?

Chen Xuan could fire 2/3 of the researchers without hesitation.

At the same time, the laboratory began external recruitment on the same day and recruited many professional talents.

The most important thing is that ordinary professionals cannot enter the laboratory, but those who can be recruited are the elites in this industry.

Even at this point, they still only recruit elites and don't want ordinary talents.

This means that Antai Pharmaceutical Group is not short of people at all, at least not to the extent that it needs to hire everyone.

In other words, this incident did not have much impact on the laboratory, which allowed us to strictly demand everyone's personal abilities.

The fact that he could do this meant that being fired would have no impact.

At the same time, it will not affect the subsequent clinical trials. If it did, the recruitment requirements would not be so high.

As for those who were causing trouble, led by Ji Mingfeng, everyone looked down on them.

You have such a good environment, but you don’t know how to cherish it. You deserve to end up like this.

And they weren't just fired.

I haven't received a penny of compensation.

Even the future career will not be easy.

With their experience, which pharmaceutical company would dare to hire them?

……

As time passed, the controversy surrounding the laboratory's dismissal gradually dissipated.

But with the advent of clinical trials, the enthusiasm has soared again.

A week later,

Clinical trials of a specific drug for lung cancer have officially begun.

This is the first phase of clinical trials, but the number of people testing the drug far exceeds that of other new drugs.

Generally, the first phase of clinical trials does not require too many people. In many cases, only ten or twenty people are enough.

Because the probability of failure in the first phase is very high.

The more people there are, the more costs will be invested.

Only later will the number of cases continue to increase.

However, the first phase of the clinical trial of Chen Xuan's special lung cancer drug was filled with 300 people.

The main reason is that there were too many people who signed up, so many that after repeated screening, there were still more than 300 people.

In the end, Chen Xuan accepted all of them very straightforwardly.

Although this will require a larger investment, the data will be more complete and convincing.

He was even more bold to start this round of clinical trials with live broadcast.

At each point, he would broadcast live so that everyone could see the entire experimental process.

The reason for doing this is purely to prove the safety of the drug.

This will allow all patients around the world to feel more at ease and not have to worry about any problems with this new drug.

"This is my first time seeing a clinical trial, and I'm curious what it will be like. I'm looking forward to it!"

"The fact that Antai Pharmaceutical Group dared to broadcast the entire process live shows that they are very confident in this new drug!"

"Nonsense! Without confidence, would Chen Xuan dare to act so arrogantly?"

"Yes, judging from the new drug data released by Antai Pharmaceutical Group, this is a groundbreaking special medicine."

"Lung cancer patients will now be saved. I hope this drug can be put on the market soon. Even if it costs a fortune, it will be a hope."

"Even if it's a sky-high priced drug, at least there's a possibility of a price reduction later. As long as the initial investment is recovered, I believe Chen Xuan will definitely lower the price."

"Are all these 300-plus people lung cancer patients? Some look very haggard. Now we've given them a chance to live."

On the eve of the clinical trial, countless netizens were looking forward to it.

Most netizens are actually unfamiliar with clinical trials, and now their knowledge gaps have been filled.

……

Antai Pharmaceutical Group!

Chen Xuan looked at the volunteers who were participating in the clinical trial.

These volunteers include both men and women, most of them are young and middle-aged, and there are very few elderly people.

As for children, Chen Xuan will not consider letting them participate in clinical trials for the time being, mainly because their physical resistance is poor and their ability to deal with unexpected situations is also poor.